All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2004-000919-26 | Phase II, randomized, pharmokinetic, dose finding, and dose frequency determination using rt-PA in intraventricular hemorrhage | 2008-08-21 | due-trials |
Completed, but no date, and reported results | 2004-001622-24 | Phase III,multicentre,open-label,prospective randomised trial comparing Imatinib alone at 400mg versus 800mg daily versus Imatinib 400mg daily plus PEG Interferon-alpha with newly diagnosed chronic my... | bad-data | |
Reported results | 2004-002262-37 | Adenosine testing in the diagnosis of unexplained syncope: A pilot study | 2005-10-31 | due-trials |
Reported results | 2004-002427-40 | What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin? | 2008-10-10 | due-trials |
Reported results Terminated | 2004-002482-20 | A Pilot Study to Test the Effect of Treating Depression Associated with Rueumatoid Arthritis (RA) using Venlaflaxine | 2007-10-16 | due-trials |
Reported results | 2004-004874-96 | Protocol: HL/IDP/PTS/001 Tumour Profiling In An Open-Labelled, 2-Arm Study Investigating The Tolerability And Efficacy Of Taxotere In Patients With High Risk Prostate Cancer | 2010-08-20 | due-trials |
Reported results | 2004-004884-31 | An open label, randomized pilot study evaluating the early conversion from calcineurin inhibitors to Rapamune in patients with impaired renal function following kidney transplantation | 2007-07-01 | due-trials |
Reported results | 2005-000707-34 | The induction of apoptosis by anti-psoriatic treatments | 2013-12-30 | due-trials |
Reported results | 2005-001007-18 | Reversal of warfarin anticoagulation with oral vitamin K: towards a better management of over-anticoagulation | 2009-03-15 | due-trials |
Not reported | 2005-003903-35 | : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis | 2009-07-31 | due-trials |
Other | 2005-004126-56 | Observational pharmacokinetic study of doxorubicin and cyclophosphamide in patients with early breast cancer. | not-yet-due | |
Reported results | 2006-000485-36 | A randomised, double blind, placebo controlled study to Assess The Effect of Antibiotic Therapy on Chronic Rejection in Human Lung Transplantation | 2011-03-31 | due-trials |
Reported results | 2006-001265-41 | A comparison of Sirolimus versus Tacrolimus as a delayed treatment of recipients of non heart beating donor kidneys after anti-IL2 monoclonal antibody | 2010-03-31 | due-trials |
Other | 2006-001774-24 | INTESTINAL MICRO-ORGANISMS IN THE PATHOGENESIS OF NASH AND THE ROLE OF MODULATION OF ENTERIC BACTERIA IN TREATMENT. | not-yet-due | |
Reported results | 2006-002042-11 | “The efficacy of inferior alveolar nerve block and buccal infiltration for pulp anaesthesia in mandibular teeth” | 2007-02-02 | due-trials |
Reported results | 2006-002047-92 | A multicentre, open-label, randomized comparison of once daily insulin detemir given pre-breakfast or bedtime, according to need, with bedtime insulin glargine in people with type 2 diabetes character... | 2010-04-28 | due-trials |
Not reported | 2006-002532-24 | Pharmacogenetic study of FcγRIIIa and HER2 genes in relation to treatment of breast cancer | 2013-08-15 | due-trials |
Reported results | 2006-002845-36 | Pharmacokinetics and pharmacogenetics of anticancer drugs in infants and young children | 2014-09-12 | due-trials |
Reported results | 2006-003745-16 | Assessment of platelet-dependent thrombosis by an ex vivo arterial injury model: a placebo controlled trial of Clopidogrel as antiplatelet therapy in patients with type 2 diabetes mellitus and coronar... | 2011-08-31 | due-trials |
Reported results | 2006-004335-29 | A randomised controlled factorial pilot study investigating Omacor and/or Fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti-viral therapy. | 2010-04-26 | due-trials |
Reported results | 2006-006127-40 | Cerebral Blood Flow following TNF-alpha Antagonism in Rheumatoid Arthritis - a Pilot Study | 2009-03-31 | due-trials |
Reported results | 2006-007056-18 | The Discoid Lupus Research Project | 2010-05-17 | due-trials |
Reported results | 2007-002357-23 | An open label, randomized 2 part crossover study to investigate the effect of buprenorphine transdermal delivery system (BTDS) compared with co-codamol on physical activity in subjects aged 60 years o... | 2009-12-29 | due-trials |
Reported results | 2007-002899-34 | Pilot Controlled Clinical Trial of Salvia Officinalis (Sage) for cognitive impairments in Parkinson's Disease | 2008-08-31 | due-trials |
Reported results | 2007-003062-18 | Immunotherapeutic Rescue of steroidogenic function in autoimmune Addison’s Disease (RAD): Pilot study | 2011-05-05 | due-trials |
Reported results | 2007-005932-10 | A double-blind randomised multi-centre, placebo-controlled trial of combined ACE-inhibitor and beta-blocker therapy in preventing the development of cardiomyopathy in genetically characterised males w... | 2018-03-23 | due-trials |
Reported results | 2007-006006-22 | Minimally Invasive Surgery plus rt-PA for ICH Evacuation | 2014-09-02 | due-trials |
Reported results | 2007-006185-15 | STI571 Prospective International RandomIsed Trial 2 - A phase III, prospective randomised comparison of imatinib (STI571, Glivec/Gleevec) 400mg daily versus dasatinib (Sprycel) 100mg daily in patient... | 2018-03-07 | due-trials |
Reported results | 2008-000224-27 | Systemic sclerosis associated interstitial lung disease: A longitudinal observational study assessing optimum treatment regimens. | 2011-07-31 | due-trials |
Reported results | 2008-003606-33 | Pilot study to investigate the feasibility of 13-cis-Retinoic acid pharmacokinetic monitoring in high-risk neuroblastoma | 2015-05-13 | due-trials |
Reported results | 2008-005395-27 | Inter-individual variability in response to warfarin in children: Analysis of environmental and pharmacogenetic factors | 2011-02-07 | due-trials |
Reported results Terminated | 2008-006238-87 | Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K | 2012-11-15 | due-trials |
Reported results Terminated | 2008-006451-52 | An investigation of the association between vitamin K intake, vitamin K epoxide reductase subunit (VKORC1) genotype and anticoagulation response to warfarin | 2012-03-14 | due-trials |
Reported results | 2009-015166-62 | A randomised controlled trial of Losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. | 2014-12-31 | due-trials |
Reported results Terminated | 2009-015170-35 | Multicentre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated with Parkinson's Disease (MUSTARDD-PD) | 2014-09-01 | due-trials |
Reported results | 2009-015396-27 | Prevention of Recurrent Severe Hypoglycaemia: a Definitive RCT Comparing Optimised MDI and CSII with or without Adjunctive Real-time Continuous Glucose Monitoring. | 2013-10-03 | due-trials |
Reported results | 2009-018074-56 | Revival of autochthonous adrenocortical stem cells in autoimmune Addison’s disease (RoSA) | 2012-09-14 | due-trials |
Reported results | 2010-019180-10 | Paramedic Initiated Lisinopril For Acute Stroke Treatment(PIL-FAST): A Pilot Randomised Controlled Trial | 2011-12-17 | due-trials |
Reported results | 2010-021146-22 | Alemtuzumab and rheumatoid arthritis - an immunisation study | 2014-11-20 | due-trials |
Reported results | 2011-000608-16 | To evaluate the safety and effectiveness of human ex vivo expanded autologous limbal stem cells for the treatment of unilateral total limbal stem cell deficiency | 2018-02-09 | due-trials |
Reported results | 2011-004425-27 | Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED) SORTED 1 – a Randomised Controlled Trial (Pilot study) SORTED 2 – Qualitative Interviews SORTED 3 – Retrospective Cohort | 2014-10-15 | due-trials |
Reported results | 2011-004890-10 | Optimising Vitamin D Status in Older People: A Randomised Controlled Trial of Vitamin D Supplementation | 2014-06-05 | due-trials |
Exempt, with results Terminated | 2011-005318-12 | Phase 1 study of use of 5% Carbogen in treatment of paediatric non-convulsive status epilepticus | 2015-01-12 | not-yet-due |
Reported results | 2011-005581-37 | Efficacy of Switch to Lopinavir/Ritonavir in Improving Cognitive function in Efavirenz treated patients | 2014-12-31 | due-trials |
Exempt, with results | 2011-005815-10 | Developmental Clinical Sciences: Does GM-CSF restore effective neutrophil function in critically ill patients? | 2015-02-12 | not-yet-due |
Reported results Terminated | 2012-000145-12 | Rituximab for the Treatment of Fatigue in Primary Biliary Cirrhosis (PBC) | 2016-09-12 | due-trials |
Reported results | 2012-001682-33 | Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison’s Disease | 2016-08-16 | due-trials |
Reported results Terminated | 2012-005696-14 | A phase 3 randomised non-inferiority trial to evaluate the use of imatinib, nilotinib and ponatinib in patients with newly-diagnosed chronic phase chronic myeloid leukaemia | 2016-09-16 | due-trials |
Other | 2013-000052-17 | Pilot study to investigate the early prediction of toxicity following induction chemotherapy in Ewing’s sarcoma by blood-borne biomarkers and correlation with age-dependent pharmacokinetic variation | not-yet-due | |
Reported results | 2013-000863-94 | A single blind study comparing the efficacy of Glycopyrronium and Hyoscine on drooling in children with neurodisability - DRI Trial (Drooling Reduction Intervention) | 2017-01-31 | due-trials |
Reported results | 2013-002556-32 | Antibiotic treatment for intermittent bladder catheterisation: A randomised controlled trial of once daily prophylaxis (The AnTIC study) | 2017-02-23 | due-trials |
Reported results | 2013-003301-26 | A randomised placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis (IPF) | 2016-09-27 | due-trials |
Reported results | 2013-004249-17 | A randomised, placebo controlled trial of extra-oesophageal reflux treatment in the management of upper respiratory symptoms. [TOPPITS: Trial of Proton Pump Inhibitors in Throat Symptoms] | 2018-03-23 | due-trials |
Other | 2014-000411-14 | A randomised double blind dose non-inferiority trial of a daily dose of 600mg versus 300mg versus 100mg of enteric coated aspirin as a cancer preventive in carriers of a germline pathological mismatch... | not-yet-due | |
Not reported | 2014-001008-23 | Riociguat in patients with respiratory disease and hypoxia – a proof-of-concept study | 2016-08-23 | due-trials |
Exempt, with results | 2014-001342-21 | Topical tropomysin kinase (TRK) inhibitor as a treatment for inherited CYLD defective skin tumours (TRAC) | 2016-07-31 | not-yet-due |
Reported results | 2014-002628-29 | Evaluating the effectiveness of intravenous ciclosporin on reducing reperfusion injury in patients undergoing primary percutaneous coronary intervention: a double-blind, phase II, randomised controlle... | 2017-11-11 | due-trials |
Reported results | 2014-004249-29 | An Open Label, Non-Randomised, Phase II study to Determine if Dabigatran and its Metabolites are Detectable in Breast Milk Following Oral Administration to Non-Breastfeeding Mothers | 2016-12-31 | due-trials |
Reported results | 2014-005475-86 | Anti-platelet Therapy in the Primary Prevention of Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease. | 2017-11-10 | due-trials |
Reported results | 2015-000508-24 | A Feasibility Study of Bezafibrate in Mitochondrial Myopathy | 2017-03-23 | due-trials |
Reported results | 2015-003195-68 | Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne Muscular Dystrophy. | 2019-03-04 | due-trials |
Reported results | 2015-003487-36 | Alternatives to prophylactic antibiotics for the treatment of recurrent urinary tract infection in women | 2020-01-27 | due-trials |
Reported results | 2016-000209-35 | Adjuvant rituximab – a potential treatment for the young patient with Graves’ hyperthyroidism | 2020-08-27 | due-trials |
Other | 2016-000997-39 | Eculizumab in Shiga-Toxin producing E. Coli Haemolytic Uraemic Syndrome (ECUSTEC): A Randomised, Double-Blind, Placebo-Controlled Trial | not-yet-due | |
Other | 2017-000893-12 | Nasal Airway Obstruction Study | not-yet-due | |
Reported results | 2017-001651-31 | EMPOWER: EMesis in Pregnancy - Ondansetron With mEtoclopRamide. | 2020-04-02 | due-trials |
Other | 2017-003916-37 | Multicentre, open label, prospective, single arm study of the safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome | not-yet-due | |
Exempt | 2018-002633-38 | An open label phase I/IIa trial repurposing carbamazepine (CBZ) for the treatment of skeletal dysplasia in children. | 2024-05-31 | not-yet-due |
Other | 2018-002721-29 | Randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in patients with Mitochondrial Myopathy | not-yet-due |